Literature DB >> 15804282

B-cell reconstitution by transplantation of B220 CD117 B-lymphoid progenitors into irradiated mice.

Susumu Kawaguchi1.   

Abstract

Bone marrow cells of 4-week-old CBA/J mice were searched for progenitors that can reconstitute CBA-type B lineage (B220+) cells after transplantation into irradiated (BALB/c x CBA/J) F(1) mice. In recipients of B lineage-committed B220+ CD117+ cells, which were CD19+ CD127+ CD25- IgM-, numbers of CBA-type B220+ cells had increased greatly by day 8 after transplantation. This increase stopped by day 10 but cell numbers remained at this level for at least 8 weeks. B-cell production in the bone marrow of B220+ CD117+ cell recipients occurred even 8 weeks after transplantation. Probably, the transplanted B-lymphoid progenitors are capable of self-renewing up to 8 weeks after transplantation. B lineage- uncommitted CD117high CD71- cells, which were B220- and included haematopoietic stem cells, could also reconstitute B lineage bone marrow cells after transplantation. Sequential development of CD117+, CD25+ and IgM+ cells in CBA-type B220+ bone marrow cells occurred 2-4 days faster in recipients of B220+ CD117+ progenitors than in recipients of CD117high CD71- progenitors, suggesting that the development of the former progenitors from the latter may take 2-4 days.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804282      PMCID: PMC1782109          DOI: 10.1111/j.1365-2567.2005.02108.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Rapid, B lymphoid-restricted engraftment mediated by a primitive bone marrow subpopulation.

Authors:  A E Searles; S J Pohlmann; L J Pierce; S S Perry; W B Slayton; M P Mojica; G J Spangrude
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

Review 2.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow.

Authors:  Irina B Mazo; Elizabeth J Quackenbush; John B Lowe; Ulrich H von Andrian
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 4.  Biology of hematopoietic stem cells and progenitors: implications for clinical application.

Authors:  Motonari Kondo; Amy J Wagers; Markus G Manz; Susan S Prohaska; David C Scherer; Georg F Beilhack; Judith A Shizuru; Irving L Weissman
Journal:  Annu Rev Immunol       Date:  2002-12-17       Impact factor: 28.527

5.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.

Authors:  S J Morrison; I L Weissman
Journal:  Immunity       Date:  1994-11       Impact factor: 31.745

6.  Expression of transferrin receptor on murine hematopoietic progenitors.

Authors:  J Lesley; R Hyman; R Schulte; J Trotter
Journal:  Cell Immunol       Date:  1984-01       Impact factor: 4.868

7.  IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development.

Authors:  A Rolink; U Grawunder; T H Winkler; H Karasuyama; F Melchers
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

8.  Hematopoietic stem cells are uniquely selective in their migratory response to chemokines.

Authors:  Douglas E Wright; Edward P Bowman; Amy J Wagers; Eugene C Butcher; Irving L Weissman
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

9.  Expression and function of c-kit in hemopoietic progenitor cells.

Authors:  M Ogawa; Y Matsuzaki; S Nishikawa; S Hayashi; T Kunisada; T Sudo; T Kina; H Nakauchi; S Nishikawa
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors.

Authors:  A Rolink; E ten Boekel; F Melchers; D T Fearon; I Krop; J Andersson
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.